Sienna concedes failure in pivotal acne trial — will the laser-managed therapy work in hair reduction?
Sienna Biopharmaceuticals’ first foray into pivotal trials is a bust.
The Westlake Village, CA biotech reported that its lead therapy, SNA-001, flunked two separate trials …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
